Ad
related to: asbestos lawsuit worth money for coronavirus 19 vaccine side effects
Search results
Results from the WOW.Com Content Network
HAMBURG (Reuters) -BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged side effects of its COVID-19 vaccine, the first of ...
A Utah mother is suing AstraZeneca after she participated in a clinical trial for the company’s COVID-19 vaccine in the fall of 2020. ... according to her lawsuit filed May 13 in federal court ...
At the time, it was the largest company ever to file bankruptcy, and was one of the richest. Manville was then 181st on the Fortune 500, but was the defendant of 16,500 lawsuits related to the health effects of asbestos. [66] The company was described by Ron Motley, a South Carolina attorney, as "the greatest corporate mass murderer in history ...
Asbestos litigation is the longest, most expensive mass tort in U.S. history, involving more than 8,000 defendants and 700,000 claimants. [1] By the early 1990s, "more than half of the 25 largest asbestos manufacturers in the US, including Amatex, Carey-Canada, Celotex, Eagle-Picher, Forty-Eight Insulations, Manville Corporation, National Gypsum, Standard Insulation, Unarco, and UNR Industries ...
The VICP was adopted in response to concerns over the pertussis portion of the DPT vaccine. [1] Several U.S. lawsuits against vaccine makers won substantial awards. Most makers ceased production, and the last remaining major manufacturer threatened to do so. [1] The VICP uses a no-fault system for resolving vaccine injury claims. [1]
Reuters reports that a U.S. judge dismissed a shareholder lawsuit claiming AstraZeneca Plc (NASDAQ: AZN) concealed problems in developing its COVID-19 vaccine, making it unlikely to win FDA approval.
The chrysotile asbestos previously used in Garlock's gaskets is roughly 1/100 to 1/2000 as carcinogenic as the friable amphibole asbestos used in the insulating tape just mentioned. Over a thirty-five year period Garlock was sued hundreds of thousands of times and forced to pay about $1.3 billion in judgements, settlements, and defense costs.
NEW YORK (Reuters) -AstraZeneca Plc on Monday won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine, making it unlikely the ...
Ad
related to: asbestos lawsuit worth money for coronavirus 19 vaccine side effects